Skip to content

Assembly Biosciences ASMB Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$9.08M-3.0%-$9.2M+4.3%-$10.2M+8.6%-$8.82M+2.9%
$26K-21.2%$32K0.0%$32K-3.0%$32K0.0%$33K+3.1%
$1.12M+56.7%$1.46M+94.5%$1.67M+110%$834K+0.1%$712K-3.7%
-$22.1M+5.7%-$15.13M+0.7%-$16.76M+2.0%-$23.44M-27.6%
$19K$24K$42K$0-100%$0-100%
-$5.38M-182%-$158.27M-746%$16.99M+233%$6.59M-61.9%
$149K-92.2%$456K-97.3%$171.93M$357K-97.1%$1.92M
-$27.33M-83.0%$35.92M+263%-$1.47M-116%$593K+29.2%-$14.93M-1,267%
-$22.12M+5.6%-$15.18M+0.5%-$16.76M+2.1%-$23.44M-27.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Assembly Biosciences generate?
Assembly Biosciences (ASMB) generated -$77.4M in operating cash flow over the trailing twelve months.
What is Assembly Biosciences's free cash flow?
After $85.0K of capital expenditures, Assembly Biosciences's free cash flow was -$77.5M over the trailing twelve months, down 51.5% year over year.
Where does Assembly Biosciences's cash flow data come from?
Every line is extracted from Assembly Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.